Clinical Trial Update: Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT [Phase 2]

View source ↗

Summary

Phase 2 randomized trial in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia evaluating chemotherapy with either imatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)
• Gleevec (Imatinib)
• Iclusig (ponatinib)

Snippet

Sponsor: Goethe University | Conditions: Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING